Baltimore, MD 20036-1984
United States
Johns Hopkins University
psoriatic arthritis, plasma proteins, pre-symptomatic biomarkers, susceptibility, converters, multivariable risk prediction, osteoclast, cobalamin, personalized medicine
Psoriatic arthristis, Composite outcome measures, Discriminant capacity, Meta-analysis, Systematic literature review, Measurement properties, Randomised controlled trial outcomes